Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction

Hypertension

Volumn 47, Issue 3 II, 2006, Pages 545-551

  Dubinion, John H ^a   Mi, Zaichuan ^a   Zhu, Chongxue ^a   Gao, Liping ^a   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension; Neuropeptides; Peptides; Receptors

Indexed keywords

ANGIOTENSIN II; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; PANCREAS POLYPEPTIDE; PEPTIDE YY; PEPTIDE YY [3-36]; PERTUSSIS TOXIN; UNCLASSIFIED DRUG; DRUG DERIVATIVE; G PROTEIN COUPLED RECEPTOR; HORMONE RECEPTOR; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y, LEU(31) PRO(34); NEUROPEPTIDE Y, LEU(31)-PRO(34)-; NPY1R PROTEIN, RAT; PANCREATIC POLYPEPTIDE RECEPTOR; PEPTIDE YY (3 36); PEPTIDE YY (3-36);

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; HYPERTENSION; KIDNEY BLOOD VESSEL; MICROVASCULATURE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; VASOCONSTRICTION; ANIMAL; ARTICLE; BLOOD VESSEL; DRUG EFFECT; GENETICS; IN VITRO STUDY; KIDNEY; MALE; METABOLISM; PATHOPHYSIOLOGY; PERFUSION; PRESSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULARIZATION; WESTERN BLOTTING; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANIMALS; BLOOD VESSELS; BLOTTING, WESTERN; HYPERTENSION; KIDNEY; MALE; NEUROPEPTIDE Y; PEPTIDE YY; PERFUSION; PRESSURE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, NEUROPEPTIDE; RECEPTORS, NEUROPEPTIDE Y; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASOCONSTRICTION;

EID: 33644984654     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000197033.54756.83     Document Type: Conference Paper

References (35)

1. Bunkenburg B, Schnell C, Baum HP, Cumin F, Wood JM. Prolonged angiotensin II antagonism in spontaneously hypertensive rats: Hemodynamic and biochemical consequences. Hypertension. 1991;18:278-288.
2. Ferrone RA, Antonaccio MJ. Prevention of the development of spontaneous hypertension in rats by captopril (SQ 14,225). Eur J Pharmacol. 1979;60:131-137.
3. Rettig R, Unger T. The role of the kidney in the aetiology of hypertension: renal transplantation studies in rats. Trends Pharmacol Sci. 1991;12:243-245.
4. Grisk O, Kloting I, Exner J, Spiess S, Schmidt R, Junghans D, Lorenz G, Rettig R. Long-term arterial pressure in spontaneously hypertensive rats is set by the kidney. J Hyperten. 2002;20:131-138.
5. Winternitz SR, Katholi RE, Oparil S. Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. J Clin Invest. 1980;66:971-978.
6. Saynavalammi P, Vaalasti A, Pyykonen ML, Ylitalo P, Vapaatalo H. The effect of renal sympathectomy on blood pressure and plasma renin activity in spontaneously hypertensive and normotensive rats. Acta Physiol Scand. 1982;115:289-293.
7. Norman RA Jr, Dzielak DJ. Role of renal nerves in onset and maintenance of spontaneous hypertension. Am J Physiol. 1982;243:H284-H288.
8. Kline RL, Kelton PM, Mercer PF. Effect of renal denervation on the development of hypertension in spontaneously hypertensive rats. Can J Physiol Pharmacol. 1978;56:818-822.
9. 2-Adrenoceptors potentiate angiotensin II and vasopressin induced renal vasoconstriction in SHR. J Pharmacol Exp Ther. 2003;305:581-586.
10. Shiono K, Sokabe H. Renin-angiotensin system in spontaneously hypertensive rats. Am J Physiol. 1976;231:1295-1299.
11. Campbell DJ, Duncan AM, Kladis A, Harrap SB. Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats. Hypertension. 1995;25:928-934.
12. Jackson EK, Herzer WA. Renal extraction of angiotensin II. J Pharmacol Exp Ther. 2003;307:1001-1006.
13. Li P, Jackson EK. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats. J Pharmacol Exp Ther. 1989;251:909-921.
14. Kost CK Jr, Jackson EK. Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat. Hypertension. 1993;21:420-431.
15. Jackson EK. Pertussis toxin normalizes enhanced renovascular responses to angiotensin II in spontaneously hypertensive rats. Life Sci. 1994;54:PL445-PL450.
16. Kost CK Jr, Herzer WA, Li PJ, Jackson EK. Pertussis toxin-sensitive G-proteins and regulation of blood pressure in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol. 1999;26:449-255.
17. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:75-197.
18. Berglund MM, Hipskind PA, Gehlert DR. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp Biol Med. 2003;228:217-244.
19. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, and Westfall T. XVI. International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev. 1998;50:143-150.
20. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 1996;382:168-171.
21. Jonsson JR, Head RJ, Frewin DB. Effect of α1-adrenoceptor blockade on the development of hypertension in the spontaneously hypertensive rat. Eur J Pharmacol. 1992;211:263-268.
22. 1 receptor contribute to blood pressure control in the spontaneously hypertensive rat? J Hypertens. 1997;15:19-27.
23. iα) in spontaneously hypertensive rats. Am J Hypertens. 1991;4:840-843.
24. Thibault C, Anand-Srivastava MB. Altered expression of G-protein mRNA in spontaneously hypertensive rats. FEBS Letters. 1992;313:160-164.
25. Anand-Srivastava MB. Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats. Relationship to adenylate cyclase inhibition. Biochem J. 1992;288:79-85.
26. Marcil J, Thibault C, Anand-Srivastava MB. Enhanced expression of Gi-protein precedes the development of blood pressure in spontaneously hypertensive rats. J Mol Cell Cardiol. 1997;29:1009-1022.
27. i proteins by pertussis toxin attenuates the development of high blood pressure in spontaneously hypertensive rats. Circ Res. 2002;91:247-254.
28. Mokkapatti R, Vyas SJ, Jackson EK. G protein mRNA expression in renal microvessels from spontaneously hypertensive and Wistar-Kyoto rats. Am J Physiol Renal. 1997;273:F877-F882.
29. 2-adrenoceptor interaction. J Pharmacol Exp Ther. 2005;314:1109-1116.
30. ++ and calmodulin. J Pharmacol Exp Ther. 1988;246:479-484.
31. Ekblad E, Edvinsson L, Wahlestedt C, Uddman R, Hakanson R, Sundler F. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Reg Peptides. 1984;8:225-235.
32. Wahlestedt C, Edvinsson L, Ekblad E, Hakanson R. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther. 1985;234:735-741.
33. Oellerich WF, Malik KU. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney. J Pharmacol Exp Ther. 1993;266:1321-1329.
34. Vonend O, Okonek A, Stegbauer J, Habbel S, Quack I, Rump LC. Renovascular effects of sympathetic cotransmitters ATP and NPY ate age-dependent in spontaneously hypertensive rats. Cardiovasc Res. 2005;66:345-352.
35. 2-adrenoceptors and angiotensin II receptors in genetic hypertension. Hypertension. 2001;38:353-360.